Meet with... Johnson & Johnson Oncology & Interventional Oncology in Basel

J&J’s INTO and Oncology external innovation teams will be in Basel on 23 October at MC3 for an exciting event “Beyond the Needle: Building the Future of Intratumoral Oncology”.

If you are involved in advancing interventional (intratumoral) approaches or systemic therapies within J&J Oncology’s priority disease areas, or the platforms, devices, treatment planning, or other enabling technologies that support them, we invite you to apply for a 1:1 meeting with our team.

Areas of interest include:

• Systemic medicines (small molecule, biologics, cell/gene therapies)
• Interventional/intratumoral therapies
• Drug-device combinations
• Radioenhancers/radiosensitizers
• Imaging-guided delivery and navigation
• Biomarkers and delivery platforms.

Application deadline – Tuesday 7 October, 17:00 CEST. Selected applicants will be notified by 14 October.

1:1 meetings are scheduled to take place in person at a J&J office near MC3. They will be held on October 23rd in the afternoon or on October 24th in the morning.